Graduate School of Medicine and Faculty of Medicine, The University of Tokyo The Department of Microbiology

日本語
|
English

Graduate School of Medicine and Faculty of Medicine, The University of Tokyo
The Department of Microbiology

Welcome to the homepage of the Department of Microbiology

Our laboratory, which was launched in September 2022, mainly studies respiratory viruses such as coronaviruses and influenza viruses, with a focus on paramyxoviruses. We aim to contribute to society by elucidating the molecular mechanisms of viral diseases. We also aim to contribute to the state-of-art medicine by developing new technologies related to recombinant virus vectors. If you are interested in viral infectious diseases or cutting-edge technologies using virus vectors, please feel free to contact us.

Article about our laboratory: Journal 'Uirus (in Japanese)' published in June 2024


Recruitment page

News & Topics

2025.06.22
Conference
Ms. Wang Yuying, a first-year doctoral student, will be presenting at the negative-strand RNA virus meeting (NSV2025)
2025.04.23
Paper
Published a joint research paper led by Institute of Science Tokyo on respiratory syncytial virus using respiratory organoids
2025.04.23
Lecture
Prof. Takeda will give a lecture at the Icahn School of Medicine at Mount Sinai in the United States.
2025.03.25
News
Ms. Kaede Tashiro has graduated with a degree.
2025.03.17
Conference
A medical student in the MD Researcher Training Program gave a poster presentation at the 2025 National Retreat
Read more

Research

Mechanisms of paramyxovirus replication - Interactions with host factors.
We study disease-causing mechanisms by searching for host factors required for paramyxoviruses such as mumps virus to multiply in cells and by clarifying their interactions with factors on the viral side.
Mechanism of Activation of Respiratory Viruses by Host Proteases
Many viruses have protein spikes (spike proteins) on the surface of their particles. We have shown that the spike proteins of various respiratory viruses are activated by a protease called TMPRSS2 in host cells.
Development and applied research on paramyxovirus vectors (e.g. development of nipah virus vaccines, development of vectors for regenerative medicine and cancer therapy)
Paramyxoviruses are used as viral vectors for gene therapy, cancer therapy, and vaccine development. We are conducting research on the development of various viral vectors for clinical applications.We are willing to accept collaborations and other research projects.
Read more

Illustrations on this website are either created by tutsi925@123RF (Natalia Krechetova) or generated by DALL·E (OpenAI).
For images generated by DALL·E (OpenAI), the copyright and usage rights are held by our laboratory.
© 2024 Department of Microbiology, The University of Tokyo.